Portfolio Holdings Detail for ISIN IE0009QS7W62
| Stock Name / Fund | MSCI Wld Hlth US A |
| Issuer | |
| Entity holding fund | iShares V Public Limited Company |
| Entity Type | |
| Entity LEI | 549300QETNU1W5JY7Z94 |
| ETF Ticker | WHCA(EUR) Euronext Amsterdam |
Holdings detail for UTHR
| Stock Name | United Therapeutics Corporation |
| Ticker | UTHR(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US91307C1027 |
| LEI | 5299005C4HZL4UWROC14 |
Show aggregate UTHR holdings
News associated with UTHR
- Envestnet Asset Management Inc. Grows Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)
- Envestnet Asset Management Inc. boosted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 5.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 60,880 shares of the biotechnology company’s stock after buying an additional 2,889 shares during the quarter. Envestnet Asset […] - 2025-04-15 08:14:52
- Cerity Partners LLC Buys 2,702 Shares of United Therapeutics Co. (NASDAQ:UTHR)
- Cerity Partners LLC grew its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 30.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,588 shares of the biotechnology company’s stock after purchasing an additional 2,702 shares during the quarter. Cerity […] - 2025-04-14 10:32:44
- Federated Hermes Inc. Increases Position in United Therapeutics Co. (NASDAQ:UTHR)
- Federated Hermes Inc. lifted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 4.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,078 shares of the biotechnology company’s stock after buying an additional 305 shares during the quarter. Federated Hermes […] - 2025-04-14 09:54:56
- Insider Selling: United Therapeutics Co. (NASDAQ:UTHR) EVP Sells $3,367,980.00 in Stock
- United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 11,000 shares of the stock in a transaction on Thursday, April 3rd. The shares were sold at an average price of $306.18, for a total value of $3,367,980.00. Following the sale, the executive vice president now owns 36,781 shares in the company, […] - 2025-04-10 08:12:55
- Raymond Dwek Sells 4,000 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stock
- United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) Director Raymond Dwek sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, April 7th. The shares were sold at an average price of $284.55, for a total value of $1,138,200.00. Following the completion of the transaction, the director now owns 1,750 shares […] - 2025-04-10 08:12:54
- United Therapeutics Co. (NASDAQ:UTHR) Given Average Rating of “Moderate Buy” by Brokerages
- Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the twelve ratings firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a […] - 2025-04-09 06:08:53
- Korea Investment CORP Increases Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
- Korea Investment CORP grew its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 6.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 39,289 shares of the biotechnology company’s stock after buying an additional 2,300 shares during the quarter. Korea Investment CORP’s holdings in United Therapeutics were worth $13,863,000 at the […] - 2025-03-31 10:40:53
- United Therapeutics Co. (NASDAQ:UTHR) Stock Position Raised by Envestnet Portfolio Solutions Inc.
- Envestnet Portfolio Solutions Inc. boosted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 8.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,082 shares of the biotechnology company’s stock after acquiring an additional 81 shares during the period. Envestnet […] - 2025-03-27 09:14:51
- Commonwealth Equity Services LLC Acquires 301 Shares of United Therapeutics Co. (NASDAQ:UTHR)
- Commonwealth Equity Services LLC increased its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 3.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,526 shares of the biotechnology company’s stock after buying an additional 301 shares during the quarter. […] - 2025-03-26 08:35:07
- M&T Bank Corp Has $1.21 Million Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
- M&T Bank Corp increased its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 9.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,429 shares of the biotechnology company’s stock after buying an additional 294 shares […] - 2025-03-11 09:34:53
- IFP Advisors Inc Trims Holdings in United Therapeutics Co. (NASDAQ:UTHR)
- IFP Advisors Inc lessened its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 18.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 855 shares of the biotechnology company’s stock after selling 194 shares during the period. […] - 2025-03-03 09:00:52
- Global Retirement Partners LLC Increases Holdings in United Therapeutics Co. (NASDAQ:UTHR)
- Global Retirement Partners LLC raised its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 38.0% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 596 shares of the biotechnology company’s stock after purchasing an additional 164 shares during the period. Global Retirement Partners LLC’s holdings in United Therapeutics were worth $210,000 as […] - 2025-02-26 09:54:53
- Blue Trust Inc. Cuts Position in United Therapeutics Co. (NASDAQ:UTHR)
- Blue Trust Inc. lowered its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 18.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,149 shares of the biotechnology company’s stock after selling 256 shares during the quarter. Blue Trust Inc.’s […] - 2025-02-18 11:06:55
- Chevy Chase Trust Holdings LLC Reduces Stake in United Therapeutics Co. (NASDAQ:UTHR)
- Chevy Chase Trust Holdings LLC reduced its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 1.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 22,726 shares of the biotechnology company’s stock after selling 323 shares during the period. […] - 2025-02-18 08:42:54
- Bleakley Financial Group LLC Purchases 389 Shares of United Therapeutics Co. (NASDAQ:UTHR)
- Bleakley Financial Group LLC increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 58.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,059 shares of the biotechnology company’s stock after purchasing an additional 389 shares during the […] - 2025-02-11 08:56:58
- Notable ETF Outflow Detected - XBI, NBIX, ALNY, UTHR
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $76.4 million dollar outflow -- that's a 1.2% decrease week over week ( - 2025-02-05 16:06:35
- Blue Trust Inc. Raises Position in United Therapeutics Co. (NASDAQ:UTHR)
- Blue Trust Inc. lifted its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 24.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,745 shares of the biotechnology company’s stock after buying an additional 340 shares during […] - 2025-01-31 08:51:09
MSCI Wld Hlth US A UTHR holdings
| Date | Number of UTHR Shares Held | Base Market Value of UTHR Shares | Local Market Value of UTHR Shares | Change in UTHR Shares Held | Change in UTHR Base Value | Current Price per UTHR Share Held | Previous Price per UTHR Share Held |
|---|
| 2025-04-17 (Thursday) | 900 | USD 256,257 | USD 256,257 | | | | |
| 2025-04-16 (Wednesday) | 900 | USD 256,671 | USD 256,671 | 0 | USD 333 | USD 285.19 | USD 284.82 |
| 2025-04-15 (Tuesday) | 900 | USD 256,338 | USD 256,338 | 0 | USD 459 | USD 284.82 | USD 284.31 |
| 2025-04-14 (Monday) | 900 | USD 255,879 | USD 255,879 | 0 | USD 2,835 | USD 284.31 | USD 281.16 |
| 2025-04-11 (Friday) | 900 | USD 253,044 | USD 253,044 | 0 | USD 2,043 | USD 281.16 | USD 278.89 |
| 2025-04-10 (Thursday) | 900 | USD 251,001 | USD 251,001 | 0 | USD -12,501 | USD 278.89 | USD 292.78 |
| 2025-04-09 (Wednesday) | 900 | USD 263,502 | USD 263,502 | 0 | USD 11,781 | USD 292.78 | USD 279.69 |
| 2025-04-08 (Tuesday) | 900 | USD 251,721 | USD 251,721 | 0 | USD -10,827 | USD 279.69 | USD 291.72 |
| 2025-04-07 (Monday) | 900 | USD 262,548 | USD 262,548 | 0 | USD -666 | USD 291.72 | USD 292.46 |
| 2025-04-04 (Friday) | 900 | USD 263,214 | USD 263,214 | 0 | USD -17,820 | USD 292.46 | USD 312.26 |
| 2025-04-02 (Wednesday) | 900 | USD 281,034 | USD 281,034 | 0 | USD 4,842 | USD 312.26 | USD 306.88 |
| 2025-04-01 (Tuesday) | 900 | USD 276,192 | USD 276,192 | 0 | USD -1,251 | USD 306.88 | USD 308.27 |
| 2025-03-31 (Monday) | 900 | USD 277,443 | USD 277,443 | 0 | USD 1,170 | USD 308.27 | USD 306.97 |
| 2025-03-28 (Friday) | 900 | USD 276,273 | USD 276,273 | 0 | USD -945 | USD 306.97 | USD 308.02 |
| 2025-03-27 (Thursday) | 900 | USD 277,218 | USD 277,218 | 0 | USD -2,520 | USD 308.02 | USD 310.82 |
| 2025-03-26 (Wednesday) | 900 | USD 279,738 | USD 279,738 | 0 | USD -5,319 | USD 310.82 | USD 316.73 |
| 2025-03-25 (Tuesday) | 900 | USD 285,057 | USD 285,057 | 11 | USD 701 | USD 316.73 | USD 319.861 |
| 2025-03-24 (Monday) | 889 | USD 284,356 | USD 284,356 | 0 | USD 6,108 | USD 319.861 | USD 312.99 |
| 2025-03-21 (Friday) | 889 | USD 278,248 | USD 278,248 | 0 | USD -542 | USD 312.99 | USD 313.6 |
| 2025-03-20 (Thursday) | 889 | USD 278,790 | USD 278,790 | 0 | USD -4,668 | USD 313.6 | USD 318.85 |
| 2025-03-19 (Wednesday) | 889 | USD 283,458 | USD 283,458 | 0 | USD 4,205 | USD 318.85 | USD 314.12 |
| 2025-03-18 (Tuesday) | 889 | USD 279,253 | USD 279,253 | 0 | USD -7,841 | USD 314.12 | USD 322.94 |
| 2025-03-17 (Monday) | 889 | USD 287,094 | USD 287,094 | 0 | USD 13,958 | USD 322.94 | USD 307.24 |
| 2025-03-14 (Friday) | 889 | USD 273,136 | USD 273,136 | 0 | USD 1,644 | USD 307.24 | USD 305.39 |
| 2025-03-13 (Thursday) | 889 | USD 271,492 | USD 271,492 | 0 | USD -1,511 | USD 305.39 | USD 307.09 |
| 2025-03-12 (Wednesday) | 889 | USD 273,003 | USD 273,003 | 0 | USD 2,374 | USD 307.09 | USD 304.42 |
| 2025-03-11 (Tuesday) | 889 | USD 270,629 | USD 270,629 | 0 | USD -11,957 | USD 304.42 | USD 317.87 |
| 2025-03-10 (Monday) | 889 | USD 282,586 | USD 282,586 | 0 | USD 1,742 | USD 317.87 | USD 315.91 |
| 2025-03-07 (Friday) | 889 | USD 280,844 | USD 280,844 | -22 | USD -2,459 | USD 315.91 | USD 310.98 |
| 2025-03-05 (Wednesday) | 911 | USD 283,303 | USD 283,303 | | | | |
| 2024-11-12 (Tuesday) | 1,164 | USD 466,613 | USD 466,613 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of UTHR by for IE0009QS7W62
Show aggregate share trades of UTHR| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-03-25 | BUY | 11 | | | 316.730* | | 313.36 |
| 2025-03-07 | SELL | -22 | | | 315.910* | | 0.00 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of UTHR
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-04-17 | 76,347 | 5,753 | 100,654 | 75.9% |
| 2025-04-16 | 100,908 | 441 | 119,070 | 84.7% |
| 2025-04-15 | 172,155 | 368 | 223,671 | 77.0% |
| 2025-04-14 | 65,848 | 206 | 133,861 | 49.2% |
| 2025-04-11 | 214,630 | 62 | 286,542 | 74.9% |
| 2025-04-10 | 113,256 | 201 | 219,439 | 51.6% |
| 2025-04-09 | 148,894 | 215 | 236,169 | 63.0% |
| 2025-04-08 | 170,352 | 99 | 242,720 | 70.2% |
| 2025-04-07 | 138,641 | 552 | 226,794 | 61.1% |
| 2025-04-04 | 140,921 | 289 | 250,242 | 56.3% |
| 2025-04-03 | 122,554 | 2,034 | 179,949 | 68.1% |
| 2025-04-02 | 84,226 | 120 | 160,167 | 52.6% |
| 2025-04-01 | 97,627 | 152 | 160,320 | 60.9% |
| 2025-03-31 | 120,162 | 56 | 207,238 | 58.0% |
| 2025-03-28 | 49,651 | 32 | 78,273 | 63.4% |
| 2025-03-27 | 79,854 | 40 | 122,176 | 65.4% |
| 2025-03-26 | 80,918 | 0 | 103,812 | 77.9% |
| 2025-03-25 | 66,033 | 24 | 116,460 | 56.7% |
| 2025-03-24 | 93,297 | 2,224 | 149,804 | 62.3% |
| 2025-03-21 | 77,622 | 0 | 109,375 | 71.0% |
| 2025-03-20 | 57,632 | 35 | 113,734 | 50.7% |
| 2025-03-19 | 66,677 | 1,715 | 160,035 | 41.7% |
| 2025-03-18 | 114,308 | 84 | 161,831 | 70.6% |
| 2025-03-17 | 139,624 | 0 | 179,773 | 77.7% |
| 2025-03-14 | 58,110 | 6 | 129,519 | 44.9% |
| 2025-03-13 | 102,993 | 19 | 193,829 | 53.1% |
| 2025-03-12 | 101,833 | 46 | 187,370 | 54.3% |
| 2025-03-11 | 141,445 | 129 | 220,644 | 64.1% |
| 2025-03-10 | 105,881 | 49 | 150,716 | 70.3% |
| 2025-03-07 | 186,879 | 133 | 250,342 | 74.6% |
| 2025-03-06 | 90,223 | 57 | 150,183 | 60.1% |
| 2025-03-05 | 86,455 | 0 | 145,270 | 59.5% |
| 2025-03-04 | 118,407 | 1 | 286,677 | 41.3% |
| 2025-03-03 | 111,142 | 13 | 252,474 | 44.0% |
| 2025-02-28 | 109,249 | 13 | 193,373 | 56.5% |
| 2025-02-27 | 201,615 | 1,178 | 362,678 | 55.6% |
| 2025-02-26 | 271,596 | 4,427 | 554,108 | 49.0% |
| 2025-02-25 | 96,004 | 12 | 279,324 | 34.4% |
| 2025-02-24 | 114,791 | 52 | 322,452 | 35.6% |
| 2025-02-21 | 79,115 | 38 | 154,200 | 51.3% |
| 2025-02-20 | 96,298 | 24 | 225,677 | 42.7% |
| 2025-02-19 | 152,291 | 327 | 228,293 | 66.7% |
| 2025-02-18 | 138,499 | 51 | 180,876 | 76.6% |
| 2025-02-14 | 43,821 | 114 | 58,219 | 75.3% |
| 2025-02-13 | 59,783 | 90 | 90,847 | 65.8% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.